submit news    HOME | FEEDBACK  


« NAVIGATION »
NEWS

- Bio/Medicine

- Chemicals

- Defense

- Drug Delivery

- Education

- Electronics

- Energy

- Events

- Grants

- Industry

- Investment

- Litigation

- Materials

- MEMS

- Nanofabrication

- Nanoparticles

- Nanotubes

- Optics

- Partnership

- Patent

- Products

- Quantum dots

- Research

- Smart Dust

- Software
COMPANIES
EVENTS

- Browse by Month

- Current Shows

- Previous Shows

- Submit Events
FEEDBACK
ADVERTISE
LINK TO US

« PARTNERS »
Become A Nanotechwire Partner

FEI Company

Veeco Instruments

Nano Science and Technology Institute

National Nanotechnology Initiative

Nanotechnology at Zyvex

Want to see your Company or Organization listed above? Become A Nanotechwire Partner Today - click here
« NEWSLETTER »



« SEARCH »







10/20/2004 1:36:16 PM
Nanolution, a Division of Biophan Technologies, to Present at Windhover Information and Medtech Insight's Prestigious ''Investment In Innovation'' Conference

Nanolution, a Division of Biophan Technologies, Inc., will be presenting on Thursday, October 21, 2004, at 11:35 a.m. ET, at Windhover Information and Medtech Insight's "Investment in Innovation" event, taking place October 21-22, 2004 at the Westin Copley Place Hotel in Boston.

Biophan, a developer of next-generation biomedical technology, recently announced the formation of its new Nanolution division to focus on implementing discoveries in nanotechnology for the purposes of drug delivery and drug elution from device surfaces. This division will broaden the applications of Biophan's extensive intellectual property portfolio, extending it from MRI safety and compatibility of devices, into to the large and rapidly growing market for drug delivery and drug elution from devices.

The first application in development is the use of nanomagnetic materials developed as part of Biophan's research into improving the MRI visibility of devices. This is a further extension of the materials used in the development of Biophan's MRI contrast agent technology -- NanoView. The same custom-tuned nanomagnetic particles that are being developed as an MRI contrast agent also enable a unique level of control for drug delivery.

Further information regarding the nanomagnetic particle technology and its applications for drug delivery is provided on the company's website; select "Drug Delivery," either PowerPoint or HTML, at http://www.biophan.com/products.php .

Other Headlines from Biophan ...
 - Biophan Licensor Issued Broad Patent on Nanomagnetic Coatings
 - Biophan Files Drug Delivery Patent for Use of NaturalNano's Halloysite Nanotubes
 - Biophan Files Broad Patent on Use of Halloysite Nanotubes for New Drug Delivery Applications
 - Biophan Joins as Senior Member of Prestigious Engineering Research Center at USC Supported by National Science Foundation
 - Biophan to Receive Nano 50 ``Best of the Best'' Award for Innovation in Nanotechnology at NASA Tech Briefs Conference

More Bio/Medicine Headlines ...
 - Researchers create nanopatch for the heart
 - Free Keithley Web-Based Seminar Addresses High Brightness LED Test Techniques
 - Leading UK Nano Organisations lend support for NANO Live UK 2011
 - Scientists Design New Anti-Flu Virus Proteins Using Computational Methods
 - New X-ray method for understanding brain disorders better


« Back To List »

« GET LISTED »
- submit company
- submit news
- submit events
- advertise here

« EVENTS »
- More Events


Copyright 2014 Nanotechwire.com | Privacy Policy |